These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9616134)

  • 21. Identification and functional characterization of imatinib-sensitive DTD1-PDGFRB and CCDC88C-PDGFRB fusion genes in eosinophilia-associated myeloid/lymphoid neoplasms.
    Gosenca D; Kellert B; Metzgeroth G; Haferlach C; Fabarius A; Schwaab J; Kneba M; Scheid C; Töpelt K; Erben P; Haferlach T; Cross NC; Hofmann WK; Seifarth W; Reiter A
    Genes Chromosomes Cancer; 2014 May; 53(5):411-21. PubMed ID: 24772479
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trisomy 8 in PDGFRB-negative cells in a patient with imatinib-sensitive chronic myelomonocytic leukemia and t(5;16)(q33;p13), PDGFRB-NDE1 fusion.
    Cavazzini F; Bardi A; Ciccone M; Rigolin GM; Gorello P; La Starza R; Mecucci C; Cuneo A
    Cancer Genet Cytogenet; 2009 Oct; 194(1):67-9. PubMed ID: 19737658
    [No Abstract]   [Full Text] [Related]  

  • 23. Myeloproliferative disorders with translocations of chromosome 5q31-35: role of the platelet-derived growth factor receptor Beta.
    Steer EJ; Cross NC
    Acta Haematol; 2002; 107(2):113-22. PubMed ID: 11919393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Huntingtin interacting protein 1 Is a clathrin coat binding protein required for differentiation of late spermatogenic progenitors.
    Rao DS; Chang JC; Kumar PD; Mizukami I; Smithson GM; Bradley SV; Parlow AF; Ross TS
    Mol Cell Biol; 2001 Nov; 21(22):7796-806. PubMed ID: 11604514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Involvement of the TEL gene in hematologic malignancy by diverse molecular genetic mechanisms.
    Golub TR; Barker GF; Stegmaier K; Gilliland DG
    Curr Top Microbiol Immunol; 1996; 211():279-88. PubMed ID: 8585959
    [No Abstract]   [Full Text] [Related]  

  • 26. Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta.
    Apperley JF; Gardembas M; Melo JV; Russell-Jones R; Bain BJ; Baxter EJ; Chase A; Chessells JM; Colombat M; Dearden CE; Dimitrijevic S; Mahon FX; Marin D; Nikolova Z; Olavarria E; Silberman S; Schultheis B; Cross NC; Goldman JM
    N Engl J Med; 2002 Aug; 347(7):481-7. PubMed ID: 12181402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel translocations that disrupt the platelet-derived growth factor receptor beta (PDGFRB) gene in BCR-ABL-negative chronic myeloproliferative disorders.
    Baxter EJ; Kulkarni S; Vizmanos JL; Jaju R; Martinelli G; Testoni N; Hughes G; Salamanchuk Z; Calasanz MJ; Lahortiga I; Pocock CF; Dang R; Fidler C; Wainscoat JS; Boultwood J; Cross NC
    Br J Haematol; 2003 Jan; 120(2):251-6. PubMed ID: 12542482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Tel-PDGFRbeta fusion gene produces a chronic myeloproliferative syndrome in transgenic mice.
    Ritchie KA; Aprikyan AA; Bowen-Pope DF; Norby-Slycord CJ; Conyers S; Bartelmez S; Sitnicka EH; Hickstein DD
    Leukemia; 1999 Nov; 13(11):1790-803. PubMed ID: 10557054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel MLL-CBP fusion transcript in therapy-related chronic myelomonocytic leukemia with a t(11;16)(q23;p13) chromosome translocation.
    Satake N; Ishida Y; Otoh Y; Hinohara S; Kobayashi H; Sakashita A; Maseki N; Kaneko Y
    Genes Chromosomes Cancer; 1997 Sep; 20(1):60-3. PubMed ID: 9290955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for a role of NF-kappaB in the survival of hematopoietic cells mediated by interleukin 3 and the oncogenic TEL/platelet-derived growth factor receptor beta fusion protein.
    Besançon F; Atfi A; Gespach C; Cayre YE; Bourgeade MF
    Proc Natl Acad Sci U S A; 1998 Jul; 95(14):8081-6. PubMed ID: 9653143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The TEL gene contributes to the pathogenesis of myeloid and lymphoid leukemias by diverse molecular genetic mechanisms.
    Golub TR; Barker GF; Stegmaier K; Gilliland DG
    Curr Top Microbiol Immunol; 1997; 220():67-79. PubMed ID: 9103676
    [No Abstract]   [Full Text] [Related]  

  • 32. A new NDE1/PDGFRB fusion transcript underlying chronic myelomonocytic leukaemia in Noonan Syndrome.
    La Starza R; Rosati R; Roti G; Gorello P; Bardi A; Crescenzi B; Pierini V; Calabrese O; Baens M; Folens C; Cools J; Marynen P; Martelli MF; Mecucci C; Cuneo A
    Leukemia; 2007 Apr; 21(4):830-3. PubMed ID: 17301821
    [No Abstract]   [Full Text] [Related]  

  • 33. The coupling of TEL/PDGFbetaR to distinct functional responses is modulated by the presence of cytokine: involvement of mitogen-activated protein kinases.
    Wheadon H; Welham MJ
    Blood; 2003 Aug; 102(4):1480-9. PubMed ID: 12714513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular cytogenetic findings in a four-way t(1;12;5;12)(p36;p13;q33;q24) underlying the ETV6-PDGFRB fusion gene in chronic myelomonocytic leukemia.
    Crescenzi B; La Starza R; Nozzoli C; Ciolli S; Matteucci C; Romoli S; Rigacci L; Gorello P; Bosi A; Martelli MF; Marynen P; Mecucci C
    Cancer Genet Cytogenet; 2007 Jul; 176(1):67-71. PubMed ID: 17574967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia.
    Golub TR; Barker GF; Bohlander SK; Hiebert SW; Ward DC; Bray-Ward P; Morgan E; Raimondi SC; Rowley JD; Gilliland DG
    Proc Natl Acad Sci U S A; 1995 May; 92(11):4917-21. PubMed ID: 7761424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIP1-ALK, a novel ALK fusion variant that responds to crizotinib.
    Fang DD; Zhang B; Gu Q; Lira M; Xu Q; Sun H; Qian M; Sheng W; Ozeck M; Wang Z; Zhang C; Chen X; Chen KX; Li J; Chen SH; Christensen J; Mao M; Chan CC
    J Thorac Oncol; 2014 Mar; 9(3):285-94. PubMed ID: 24496003
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The t(8;13)(p11;q11-12) rearrangement associated with an atypical myeloproliferative disorder fuses the fibroblast growth factor receptor 1 gene to a novel gene RAMP.
    Smedley D; Hamoudi R; Clark J; Warren W; Abdul-Rauf M; Somers G; Venter D; Fagan K; Cooper C; Shipley J
    Hum Mol Genet; 1998 Apr; 7(4):637-42. PubMed ID: 9499416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RET fusion genes are associated with chronic myelomonocytic leukemia and enhance monocytic differentiation.
    Ballerini P; Struski S; Cresson C; Prade N; Toujani S; Deswarte C; Dobbelstein S; Petit A; Lapillonne H; Gautier EF; Demur C; Lippert E; Pages P; Mansat-De Mas V; Donadieu J; Huguet F; Dastugue N; Broccardo C; Perot C; Delabesse E
    Leukemia; 2012 Nov; 26(11):2384-9. PubMed ID: 22513837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Huntingtin interacting protein 1 is a novel brain tumor marker that associates with epidermal growth factor receptor.
    Bradley SV; Holland EC; Liu GY; Thomas D; Hyun TS; Ross TS
    Cancer Res; 2007 Apr; 67(8):3609-15. PubMed ID: 17440072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ARG tyrosine kinase activity is inhibited by STI571.
    Okuda K; Weisberg E; Gilliland DG; Griffin JD
    Blood; 2001 Apr; 97(8):2440-8. PubMed ID: 11290609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.